# ColoSense Post-Approval Study

> **NCT07069556** · — · RECRUITING · sponsor: **Geneoscopy, Inc.** · enrollment: 12500 (estimated)

## Conditions studied

- Colorectal Cancer (Diagnosis)

## Interventions

- **DEVICE:** ColoSense

## Key facts

- **NCT ID:** NCT07069556
- **Lead sponsor:** Geneoscopy, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2028-09-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 12500 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069556, "ColoSense Post-Approval Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07069556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*